Publication | Closed Access

A phase II study of irinotecan alternated with five days bolus of 5-fluorouracil and leucovorin in first-line chemotherapy of metastatic colorectal cancer

Days BolusMedicinePharmacologyColorectal CancerMetastatic Colorectal CancerPhase Ii StudyPharmacotherapyAnti-cancer AgentCancer TreatmentOncologyRadiation Oncology